Home » Topics » Regulatory

Regulatory
RSS

FDA approves expanded indications for Dynabac

March 6, 1998

FDA okays labeling change for Pulmozyme

March 3, 1998

Once-daily formulation of paroxetine submitted for FDA review

March 3, 1998

Alferon N Injection for HIV-infected patients makes progress

Feb. 26, 1998

Floxin Otic launched in U.S.

Feb. 24, 1998

Beneficial effects of lisinopril on progression of retinopathy in IDDM

Feb. 20, 1998

Rebif launched in Canada: first drug to delay disease progression in remitting-relapsing MS

Feb. 20, 1998

New octreotide formulation launched in Italy

Feb. 20, 1998

FDA approves new indication for pilocarpine

Feb. 19, 1998

New once-daily antihypertensive combination available in U.S.

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...